期刊文献+

乳腺肿瘤摄取^(99)Tc^m-MIBI与预后因子的关系 被引量:7

Correlation between uptake of ^(99)Tc^m-MIBI and prognostic factors of breast cancer
暂未订购
导出
摘要 目的 对99Tcm 甲氧基异丁基异腈 (MIBI)乳腺显像真阳性患者的肿瘤99Tcm MIBI摄取程度与腋窝淋巴结转移、组织分级、增殖细胞核抗原 (PCNA)、雌激素受体 (ER)、孕激素受体 (PR)、c erbB 2、p5 3等预后因子之间的关系进行研究。方法  44例99Tcm MIBI乳腺显像真阳性的患者 ,平均年龄 5 4.9岁。对显像阳性的肿块计算肿块感兴趣区 (ROI)与对侧正常相应部位放射性计数比值 (T N)。病理检查诊断按照HE染色和ER、PR、PCNA、p5 3和c erbB 2的免疫组织化学染色。根据WHO标准并参照Bloom Richardson标准对HE染色切片进行组织学分级 ;并对肿瘤细胞PCNA免疫组织化学染色核染色的数目和形态进行Ⅰ~Ⅲ级评分 ;余免疫组织化学染色项目仅以阳性与否进行判别。结果 肿瘤T N值与肿瘤的组织分级、腋窝淋巴结转移、PCNA和c erbB 2之间经非参数相关性分析 ,相关系数分别为 0 .44 6 ,0 .2 2 4,0 .32 3和 0 .332 ,P值分别为 0 .0 0 1,0 .0 38,0 .0 0 4和 0 .0 0 4。余各指标差异无显著性。病理组织分级为Ⅰ~Ⅲ级的肿瘤T N值分别为 1.2 4± 0 .13,1.42± 0 .18和 1.6 1± 0 .30 ,经方差分析Ⅰ级和Ⅲ级之间差异有显著性 (P =0 .0 0 1) ;有和无腋窝淋巴结转移乳腺癌的T N值为1 5 4± 0 .2 4和 1.39± 0 .2 3(P =0 0 2 6 )。 Objective Assessment of correlation between 99 Tc m-MIBI uptake and some prognostic factors of breast cancer. The following prognostic factors were included in this study: axillary node involvement, grading of tumor with WHO standard, proliferating cell nuclear antigen (PCNA), oestrogen and progesterone receptor (ER, PR) status, c-erbB-2 antigen expression and p53 protein. Methods Forty-four patients were enrolled in this study confirmed as with primary breast cancers. Mean age of the patients was 54.9 years. Scintimammography was performed after intravenous injection of 740~1 110 MBq of 99 Tc m-MIBI. At 5~10 min after injection standard planar images were obtained in anterior supine and prone lateral views. Assessment of correlation between the known prognostic factors of breast cancer and the uptake of MIBI (evaluated as a tumor to mirror normal ratio, T/N ratio was performed using non-parametric (Kendalltau correlation) statistical analysis. Results There was positive correlation between T/N ratio 99 Tc m-MIBI and the grade of the breast tumor ( r=0.446,P =0.001),presence of axillary node involvement ( r=0.224,P =0.038), the grade of PCNA ( r=0.323, P= 0.004) and also the status of c-erbB-2 antigen expression ( r=0.332, P=0.0 04), respectively. The remaining prognostic factors showed no obvious correlation with T/N ratio 99 Tc m-MIBI. T/N ratio of breast cancer of grade Ⅰ~Ⅲ were 1.24±0.13,1.42±0.18 and 1.61±0.30, respectively. There was statistical significance between T/N ratio of grade Ⅰ and grade Ⅲ, P =0.001. T/N ratio of with/ without involvement of axillary nodes was 1.54±0.24 and 1.39±0.23, P =0.026. Conclusions Patients who presented with high grade of malignancy had higher uptake of radiotracer. Also those with higher uptake of radiotracer often had axillary node involvement. This would suggest that more aggressive tumors have higher uptake of 99 Tc m-MIBI. Finally, this study suggests correlation between in vivo uptake of 99 Tc m-MIBI and some of the known prognostic factors of breast cancer.
出处 《中华核医学杂志》 CAS CSCD 北大核心 2002年第1期19-21,共3页 Chinese Journal of Nuclear Medicine
关键词 乳腺肿瘤 放射性核素显像 MIBI 预后 诊断 评估 Mammary neoplasms Radionuclide imaging MIBI Prognosis
  • 相关文献

参考文献4

二级参考文献4

  • 1潘中允,临床核医学,1994年
  • 2Lam W W M,Eur J Nucl Med,1996年,23期,498页
  • 3Piwniaca Worms D,Circulation,1990年,82期,1826页
  • 4Maublant J C,J Nucl Med,1988年,29卷,48页

共引文献52

同被引文献70

  • 1林大任,黄河,李明毅,黄斌豪.乳腺癌^(99m)Tc-MIBI影像与P-糖蛋白表达的相关性[J].中华肿瘤防治杂志,2006,13(9):695-696. 被引量:4
  • 2Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst, 2000, 92( 3 ): 205-216.
  • 3Londero V, Bazzocchi M, Del Frate C, et al. Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women reeeiving neoadjuvant chemotherapy. Eur Radiol, 2004, 14( 8 ): 1371-1379.
  • 4Huber S, Medl M, Helbich T, et al. Locally advanced breast carcinoma: computer assited semiqutitative analysis of color Doppler uhrasonography in the evaluation of tumor response to neoadjuvant chemotherapy (work in progress). J Ultrasound Med, 2000, 19(9): 601-607.
  • 5Kuerer HM, Newman LA, Buzdar AU, et al. Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer. Am J Surg, 1998, 176(6): 502-509.
  • 6Londero V, Bazzocchi M, Ded Frate C, et al. Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol, 2004, 14(8): 1371-1379.
  • 7Delille JP, Slanetz PJ, Yeh ED, et al. Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: noninvasive monitoring with functional MR hnaging pilot Study. Radiology, 2003, 228(1) : 63-69.
  • 8Pickles MD, Lowry M, Manton DJ, et al. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Breast Cancer Res Treat, 2005, 91(1): 1-10.
  • 9Rieber A, Zeitler H, Rosenthal H, et al. MR1 in breast cancer: influence of chemotherapy on sensitivity. Br J Radiol, 1997, 70 (833): 452-458.
  • 10Wan'en RM, Bobrow LG, Earl HM, et al. Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy?. Br J Cancer, 2004, 90 (7): 1349- 1360.

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部